摘要
目的:探讨16F引流管胸腔引流对肺癌(LC)患者胸腔镜肺叶切除术后舒适度的影响。方法:对本院63例肺癌胸腔镜肺叶切除术后行胸腔引流的患者进行分析,采集数据的时间为2018年3月-2020年5月,按照计算机随机生成数字法,分为对照组(31例)和观察组(32例),对照组予28F引流管进行胸腔引流,观察组予16F引流管进行胸腔引流,比较两组舒适度、术后疼痛情况、引流情况、平均住院时间及术后并发症。结果:观察组舒适度明显高于对照组(P<0.05)。术后1、3、5 d,观察组VAS评分明显低于对照组(P<0.05)。观察组引流持续时间及平均住院时间明显短于对照组,观察组引流量少于对照组(P<0.05)。观察组术后并发症总发生率3.13%,明显低于对照组25.81%(P<0.05)。结论:16F引流管进行胸腔引流具有更好的舒适度,可以缓解术后疼痛,改善引流情况和平均住院时间,减少术后并发症发生率。
Objective:To investigate the influence of thoracic drainage with 16F drainage tube on the comfort of lung cancer(LC)patients after thoracoscopic lobectomy.Method:A total of 63 patients with lung cancer after thoracoscopic lobectomy who underwent thoracoscopic lobectomy were analyzed.The data were collected from March 2018 to May 2020.According to the computer generated digital method,the data were divided into control group(31 cases)and observation group(32 cases).The control group was treated with 28F drainage tube for thoracic drainage,and the observation group was treated with 16F drainage tube for thoracic drainage.The comfort degree,postoperative pain,drainage and average hospitalization time and postoperative complications were compared between the two groups.Result:The comfort degree of the observation group was significantly higher than that of the control group(P<0.05).Postoperative 1,3,5 d,the VAS score of observation group was significantly lower than that of the control group(P<0.05).The duration of drainage and average hospitalization time in the observation group were significantly shorter than those in the control group,and the drainage volume in the observation group was less than that in the control group(P<0.05).The total incidence of postoperative complications in the observation group was 3.13%,which was significantly lower than 25.81%of the control group(P<0.05).Conclusion:The 16F drainage tube for thoracic drainage has better comfort,can relieve postoperative pain,improve drainage and average hospitalization time,and reduce the incidence of postoperative complications.
作者
麦伟豪
林立尧
李加
颜妃大
郑美乔
MAI Weihao;LIN Liyao;LI Jia;YAN Feida;ZHENG Meiqiao(The Second Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,China;不详)
出处
《中外医学研究》
2021年第24期136-138,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH